Enteral Feeding Tubes Market

Parenteral to Enteral Feeding – Shift is Bolstering Growth of the Enteral Feeding Tubes Market

The Enteral Feeding Tubes Market is valued at USD 3.4 Bn in 2026 and is projected to reach USD 5 Bn,  growing at a CAGR of 5% by 2033.Shift from parenteral nutrition towards enteral feeding continues to remain a potential influencer for growth of the enteral feeding tubes market. Benefit of enteral feeding being improvement in intestinal blood flow stimulation along due to enhanced maintenance of the GI mucosal barrier has driven the adoption of enteral feeding worldwide. In addition, enteral feeding also enhances pancreatic functionalities alongside maintaining mass of small intestine, improving healing and recovery quotient, reducing risk of infection and lowering muscle catabolism. According to the analysis of German Medical Science Journal, septic complications impact around 3% individuals that are on enteral feeding, as compared to over 20% of those who are on parenteral nutrition. The transition to enteral from parenteral feeding has significantly bolstered the growth of the enteral feeding tubes market.

Oncology to Largely Contribute to the Enteral Feeding Tubes Market Growth

Demand for enteral feeding tubes from the oncology domain is poised to witness a significant spike in the years to follow. Increasing prevalence of cancer cases has spurred use of enteral feeding tubes to provide optimum nutrition to cancer affected patients. Individuals suffering from Head and Neck Squamous Cell Cancer (HNSCC) experience anorexia, weight loss, anaemia, and asthenia. In these cases, presence of tumors near oesophageal tissue and the corresponding damage from treatments result in poor weight management along with inadequate nutritional flow. This resulted in an increase in the use of enteral feeding tubes to supplement the patient with adequate nutrition. According to the World Health Organization (WHO), in 2020, cancer accounted for about 10 million deaths. Additionally, American Society of Clinical Oncology (ASCO) analysis reflected that over 66,600 individuals in the United States developed head and neck cancer.

Additionally, gastric cancer is the fifth common chronic disease and a third leading death cause worldwide. World Health Organization reveals that about 1.09 million individuals were diagnosed with stomach cancer on the global front. The anorexia-cachexia syndrome in stomach is caused mainly due to obstruction in the upper digestive tract, given the mechanical tumour effects. Hence, nutrition flow through enteral feeding has been an apt recommendation to patients suffering from this syndrome. In this background, increasing prevalence of cancer is expected to fuel the growth of the market.

Asia Pacific Likely to Showcase Higher Dependence on Enteral Feeding

Asia Pacific region is expected to showcase high growth potential with respect to adoption of enteral feeding tubes in the coming years. Emerging economies such as India and China, that are highly populated, are poised to have a significant share in the Asia Pacific enteral feeding tubes market. This can be attributed towards increasing incidences of preterm births coupled with growing aging population in these countries. According to World Health Organization (WHO), during 2015-2016, preterm births across China crossed 1.7 million, while preterm births in India alone touched a peak of more than 3 million in 2016. This statistics is expected to further increase in the following years, says WHO. Against this backdrop, it is imperative to enhance feeding of a premature baby in order to shun the mortality rate. UNICEF analysis shows that in 2018, around 2.5 million newborn mortalities were recorded in India off which major accountability was from preterm births. This aspect has pushed the need for enteral nutrition, in turn influencing growth of the market.

In addition, rising number of cancer incidences across India and China is another factor triggering demand for enteral nutrition. According to the Indian Council of Medical Research (IMCR), in 2018, more than 1.1 million cancer cases were observed in India, touching a count of over 1.7 million in 2020. This prompted enteral feeding to cancer patients that require high nutrition during the phase. This factor complements the growth of the regional market.

Key players in the market are focusing on growth strategies such as product expansion, partnerships, and collaborations to improve their market position. For instance, in 2021, Syncro Medical Innovations Inc., and Hatch Medical LLC partnered to commercialize GFTB (Gabriel Feeding Tube with Balloon). In 2020, Applied Medical Technology Inc. expanded its G-JET offering to include gastric-jejunal feeding tube in its G-JET portfolio.

Few of the major players operating in the enteral feeding tubes market include 

• Becton, Dickinson and Company (BD)
• Medtronic plc
• Smiths Medical (ICU Medical)
• Fresenius Kabi
• Cardinal Health, Inc.
• Avanos Medical (formerly Kimberly Clark Health Care)
• Halyard Health (now part of Owens & Minor)
• Teleflex Incorporated
• ConvaTec Group plc
• Molnlycke Health Care
• Stryker Corporation
• Cook Medical
• Vygon Group
• Parker Laboratories, Inc

By Tube Type

• Nasogastric (NG) Tubes
• Nasojejunal (NJ) Tubes
• Gastrostomy (G) Tubes
• Jejunostomy (J) Tubes
• Percutaneous Endoscopic Gastrostomy (PEG) Tubes
• Percutaneous Endoscopic Jejunostomy (PEJ) Tubes
• Oroenteric / Nasoenteric Tubes
• Others

By Application

• Oncology
• Gastroenterology
• Neurology
• Critical Care / ICU
• Diabetes
• Geriatrics
• Others

By Age Group

• Pediatric
• Adult

By End User

• Hospitals
• Home Care Settings
• Ambulatory Surgical Centers
• Long-Term Care Centers
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa